131 related articles for article (PubMed ID: 1657423)
1. Synthesis of the spin-labeled derivative of an ether-linked phospholipid possessing high antineoplastic activity.
Joseph J; Shih CC; Lai CS
Chem Phys Lipids; 1991; 58(1-2):19-26. PubMed ID: 1657423
[TBL] [Abstract][Full Text] [Related]
2. Molecular dynamics of antitumor ether-linked phospholipids in model membranes: a spin-label study.
Lai CS; Joseph J; Shih CC
Biochem Biophys Res Commun; 1989 May; 160(3):1189-95. PubMed ID: 2543392
[TBL] [Abstract][Full Text] [Related]
3. Synthesis of 1-O-alkyl-2-O-methyl-glycerophospholipids with potential antitumor activity.
Alunni-Bistocchi G; Orvietani PL; Ricci A; Binaglia L; Orlando M; Orlando P
Farmaco; 1990 May; 45(5):499-509. PubMed ID: 2222722
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and growth inhibitory properties of glycosides of 1-O-hexadecyl-2-O-methyl-sn-glycerol, analogs of the antitumor ether lipid ET-18-OCH3 (edelfosine).
Marino-Albernas JR; Bittman R; Peters A; Mayhew E
J Med Chem; 1996 Aug; 39(17):3241-7. PubMed ID: 8765506
[TBL] [Abstract][Full Text] [Related]
5. Flow cytometric monitoring of anthracycline accumulation after anti-neoplastic ether phospholipid treatment.
Principe P; Faussat-Suberville AM; Coulomb H; Marie JP; Braquet P
Anticancer Drugs; 1994 Jun; 5(3):329-35. PubMed ID: 7919458
[TBL] [Abstract][Full Text] [Related]
6. Synthesis of a spin-labeled phospholipid for studying membrane dynamics in intact mammalian cells.
Joseph J; Lai CS
J Lipid Res; 1988 Aug; 29(8):1101-4. PubMed ID: 2846731
[TBL] [Abstract][Full Text] [Related]
7. Effects of antineoplastic ether lipids on model and biological membranes.
Noseda A; Godwin PL; Modest EJ
Biochim Biophys Acta; 1988 Nov; 945(1):92-100. PubMed ID: 3179313
[TBL] [Abstract][Full Text] [Related]
8. Induction of apoptosis in human leukemic cells by the ether lipid 1-octadecyl-2-methyl-rac-glycero-3-phosphocholine. A possible basis for its selective action.
Diomede L; Colotta F; Piovani B; Re F; Modest EJ; Salmona M
Int J Cancer; 1993 Jan; 53(1):124-30. PubMed ID: 8416196
[TBL] [Abstract][Full Text] [Related]
9. Selective induction of apoptosis in cancer cells by the ether lipid ET-18-OCH3 (Edelfosine): molecular structure requirements, cellular uptake, and protection by Bcl-2 and Bcl-X(L).
Mollinedo F; Fernández-Luna JL; Gajate C; Martín-Martín B; Benito A; Martínez-Dalmau R; Modolell M
Cancer Res; 1997 Apr; 57(7):1320-8. PubMed ID: 9102220
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and antineoplastic properties of ether-linked thioglycolipids.
Guivisdalsky PN; Bittman R; Smith Z; Blank ML; Snyder F; Howard S; Salari H
J Med Chem; 1990 Sep; 33(9):2614-21. PubMed ID: 2391700
[TBL] [Abstract][Full Text] [Related]
11. Tumor cell kinetics following antineoplastic ether phospholipid treatment.
Principe P; Sidoti C; Braquet P
Cancer Res; 1992 May; 52(9):2509-15. PubMed ID: 1568220
[TBL] [Abstract][Full Text] [Related]
12. Syntheses of racemic and nearly optically pure ether lipids and evaluation of in vitro antineoplastic activities.
Duclos RI; Chia HH; Abdelmageed OH; Esber H; Fournier DJ; Makriyannis A
J Med Chem; 1994 Nov; 37(24):4147-54. PubMed ID: 7990114
[TBL] [Abstract][Full Text] [Related]
13. The conformational properties of the antineoplastic ether lipid 1-thiohexadecyl-2-O-methyl-S-glycero-3-phosphocholine.
Mavromoustakos T; Theodoropoulou E; Yang DP; Lin SY; Koufaki M; Makriyannis A
Chem Phys Lipids; 1996 Nov; 84(1):21-34. PubMed ID: 8952050
[TBL] [Abstract][Full Text] [Related]
14. Membrane peroxidative damage enhancement by the ether lipid class of antineoplastic agents.
Wagner BA; Buettner GR; Burns CP
Cancer Res; 1992 Nov; 52(21):6045-51. PubMed ID: 1394229
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and biological activity of novel quaternary ammonium derivatives of alkylglycerols as potent inhibitors of protein kinase C.
Marasco CJ; Piantadosi C; Meyer KL; Morris-Natschke S; Ishaq KS; Small GW; Daniel LW
J Med Chem; 1990 Mar; 33(3):985-92. PubMed ID: 2308148
[TBL] [Abstract][Full Text] [Related]
16. Cytotoxic effects of ether lipids and derivatives in human nonneoplastic bone marrow cells and leukemic cells in vitro.
Schick HD; Berdel WE; Fromm M; Fink U; Jehn U; Ulm K; Reichert A; Eibl H; Unger C; Rastetter J
Lipids; 1987 Nov; 22(11):904-10. PubMed ID: 3444383
[TBL] [Abstract][Full Text] [Related]
17. Enzymatic release of antitumor ether lipids by specific phospholipase A2 activation of liposome-forming prodrugs.
Andresen TL; Davidsen J; Begtrup M; Mouritsen OG; Jørgensen K
J Med Chem; 2004 Mar; 47(7):1694-703. PubMed ID: 15027860
[TBL] [Abstract][Full Text] [Related]
18. An efficient new route to plasmenyl-type lipids: synthesis and cytotoxicity of a plasmenylcholine analogue of the antitumor ether lipid ET-18-OMe.
Shin J; Qualls MM; Boomer JA; Robarge J; Thompson DH
J Am Chem Soc; 2001 Jan; 123(3):508-9. PubMed ID: 11456559
[No Abstract] [Full Text] [Related]
19. Correlation of ether lipid content of human leukemia cell lines and their susceptibility to 1-O-octadecyl-2-O-methyl-rac-glycero-3-phosphocholine.
Chabot MC; Wykle RL; Modest EJ; Daniel LW
Cancer Res; 1989 Aug; 49(16):4441-5. PubMed ID: 2743333
[TBL] [Abstract][Full Text] [Related]
20. Antineoplastic ether-linked phospholipid induces differentiation of acute myelogenous leukemic KG-1 cells into macrophage-like cells.
Reed CB; Tang W; Ziboh VA
Life Sci; 1991; 49(17):1221-7. PubMed ID: 1943437
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
